Skip to main content

REVIEW article

Front. Pharmacol.

Sec. Experimental Pharmacology and Drug Discovery

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1555732

This article is part of the Research Topic Advancements in P2X7 Antagonists: From Mechanistic Insights to Therapeutic Applications View all articles

Focus on P2X7R in Microglia: Its Mechanism of Action and Therapeutic Prospects in Various Neuropathic Pain Models

Provisionally accepted
Kai Zhang Kai Zhang 1,2Rui Ran Rui Ran 1,2Cheng-Jun Zhang Cheng-Jun Zhang 3Linna Wang Linna Wang 3Haihong Zhang Haihong Zhang 1*
  • 1 Lanzhou University Second Hospital, Lanzhou, China
  • 2 Orthopedics Key Laboratory of Gansu Province, Lanzhou, Gansu Province, China
  • 3 Lanzhou Biotechnique Development Co., Ltd, Lanzhou, Gansu Province, China

The final, formatted version of the article will be published soon.

    Neuropathic pain (NP) is a common symptom of many diseases and is caused by direct or indirect damage to the nervous system. Tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors are typical drugs used in clinical practice to suppress pain. However, these drugs have drawbacks, including a short duration of action, a limited analgesic effect, and possible dependence and side effects. Therefore, developing more effective NP treatment strategies has become a priority in medical research and has attracted much research attention. P2X7 receptor (P2X7R) is a non-selective cation channel activated by adenosine triphosphate and is mainly expressed in microglia in the central nervous system. Microglial P2X7R plays an important role in pain regulation, suggesting that it could be a potential target for drug

    Keywords: neuropathic pain, P2X7R, Microglia, M1/M2 polarization, cytokine, Neuroinflammation

    Received: 05 Jan 2025; Accepted: 07 Mar 2025.

    Copyright: © 2025 Zhang, Ran, Zhang, Wang and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Haihong Zhang, Lanzhou University Second Hospital, Lanzhou, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more